Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
11 2020
Historique:
received: 28 05 2020
revised: 12 08 2020
accepted: 13 08 2020
pubmed: 18 8 2020
medline: 15 12 2020
entrez: 18 8 2020
Statut: ppublish

Résumé

In multiple sclerosis (MS), a subset of chronic active white matter lesions are identifiable on magnetic resonance imaging by their paramagnetic rims, and increasing evidence supports their association with severity of clinical disease. We studied their potential role in differential diagnosis, screening an international multicenter clinical research-based sample of 438 individuals affected by different neurological conditions (MS, other inflammatory, infectious, and non-inflammatory conditions). Paramagnetic rim lesions, rare in other neurological conditions (52% of MS vs 7% of non-MS cases), yielded high specificity (93%) in differentiating MS from non-MS. Future prospective multicenter studies should validate their role as a diagnostic biomarker. ANN NEUROL 2020;88:1034-1042.

Identifiants

pubmed: 32799417
doi: 10.1002/ana.25877
pmc: PMC9943711
mid: NIHMS1873502
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034-1042

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS082347
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA NS003119
Pays : United States

Informations de copyright

© 2020 American Neurological Association.

Références

Mult Scler. 2016 Sep;22(10):1289-96
pubmed: 26658816
Mult Scler. 2020 Apr;26(4):421-432
pubmed: 31536435
J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):749-755
pubmed: 28705900
J Clin Invest. 2016 Jul 1;126(7):2597-609
pubmed: 27270171
Mult Scler. 2021 Jun;27(7):1057-1065
pubmed: 32749948
Ann Neurol. 2019 Jun;85(6):934-942
pubmed: 30847935
NMR Biomed. 2020 May;33(5):e4283
pubmed: 32125737
Radiology. 2012 Dec;265(3):926-32
pubmed: 23074257
JAMA Neurol. 2013 May;70(5):623-8
pubmed: 23529352
Ann Neurol. 2018 Feb;83(2):283-294
pubmed: 29328521
Neurology. 2005 Apr 12;64(7):1144-51
pubmed: 15824338
Radiology. 2012 Jan;262(1):206-15
pubmed: 22084205
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 22;3(4):e259
pubmed: 27489865
Mult Scler. 2012 Nov;18(11):1592-9
pubmed: 22711711
Lancet. 1990 May 5;335(8697):1078-80
pubmed: 1970380
JAMA Neurol. 2018 Dec 1;75(12):1546-1553
pubmed: 30167654
AJNR Am J Neuroradiol. 2020 Jun;41(6):1001-1008
pubmed: 32439639
Acta Neuropathol. 2018 Apr;135(4):511-528
pubmed: 29441412
J Thromb Haemost. 2006 Feb;4(2):295-306
pubmed: 16420554
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Acta Neuropathol. 2017 Jan;133(1):25-42
pubmed: 27796537
Mult Scler. 2014 Oct;20(11):1464-70
pubmed: 24639479
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
PLoS One. 2015 Jul 17;10(7):e0128386
pubmed: 26186349
Nat Rev Neurol. 2016 Dec;12(12):714-722
pubmed: 27834394
Nat Rev Neurol. 2017 Sep;13(9):567-572
pubmed: 28799551
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Neurology. 2016 Sep 27;87(13):1393-9
pubmed: 27581217
AJNR Am J Neuroradiol. 2018 Oct;39(10):1806-1813
pubmed: 30213803
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1287-1295
pubmed: 28103199
Mult Scler. 2017 Dec;23(14):1938-1946
pubmed: 28155580
Nat Rev Neurol. 2013 Jun;9(6):307-16
pubmed: 23628737
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
AJNR Am J Neuroradiol. 2018 Jul;39(7):1233-1238
pubmed: 29724768
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Ann Neurol. 2015 Nov;78(5):710-21
pubmed: 26239536
Radiology. 2014 Apr;271(1):183-92
pubmed: 24475808
JAMA Neurol. 2019 Dec 1;76(12):1446-1456
pubmed: 31424490
Mult Scler Relat Disord. 2019 May;30:51-56
pubmed: 30738280
Neurology. 2011 Feb 8;76(6):534-9
pubmed: 21300968

Auteurs

Pietro Maggi (P)

Department of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Pascal Sati (P)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.
Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA.

Govind Nair (G)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Irene C M Cortese (ICM)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Steven Jacobson (S)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Bryan R Smith (BR)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Avindra Nath (A)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Joan Ohayon (J)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Vincent van Pesch (V)

Department of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Gaetano Perrotta (G)

Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Caroline Pot (C)

Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Marie Théaudin (M)

Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Vittorio Martinelli (V)

Departments of Neurology and Neurophysiology and Neuroimaging Research Unit, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.

Roberta Scotti (R)

Department of Neuroradiology, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.

Tianxia Wu (T)

Clinical Trials Unit, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Renaud Du Pasquier (R)

Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Peter A Calabresi (PA)

Department of Neurology, Johns Hopkins University, Baltimore, MD.

Massimo Filippi (M)

Departments of Neurology and Neurophysiology and Neuroimaging Research Unit, Ospedale San Raffaele and Università Vita e Salute, Milan, Italy.

Daniel S Reich (DS)

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD.

Martina Absinta (M)

Department of Neurology, Johns Hopkins University, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH